Results 61 to 70 of about 273 (101)

Investigation of antibiotic targets in the decaprenyl-phosphorylarabinose biosynthesis in m. tuberculosis [PDF]

open access: yes, 2019
An estimated 1.67 million people died of tuberculosis (TB) in 2016 and it is a threat to human life on a global-scale. To shorten current treatments and battle drug resistant strains it is important to discover and develop new drugs against the causative
Tóth, Szilvia
core  

Innovate to Eradicate:Refining Tuberculosis Drug Discovery through Zebrafish [PDF]

open access: yes
Tuberculosis (TB) remains one of the oldest and most persistent infectious diseases, posing a significant global health challenge with over 10 million new infections annually.
Habjan, Eva
core   +1 more source

Staph wars: the antibiotic pipeline strikes back. [PDF]

open access: yesMicrobiology (Reading), 2023
Douglas EJA, Laabei M.
europepmc   +1 more source

The activity of nybomycin against mycobacterium tuberculosis. [PDF]

open access: yes, 2018
Doctoral Degree. University of KwaZulu-Natal, Durban.Nybomycin was discovered in 1955, but was never developed for clinical use. The compound was noticed again in recent years when it displayed bactericidal activity against certain fluoroquinolone ...
Niehaus, Abraham Johannes.
core  

Identification of Mycobacterium tuberculosis Resistance to Common Antibiotics: An Overview of Current Methods and Techniques [PDF]

open access: yes
Xue-Song Xiong,1,2,* Xue-Di Zhang,3,* Jia-Wei Yan,3 Ting-Ting Huang,1,2 Zhan-Zhong Liu,4 Zheng-Kang Li,5 Liang Wang,5 Fen Li1,2 1Department of Laboratory Medicine, The Affiliated Huai’an Hospital of Yangzhou University, Huai’an, Jiangsu Province,
Huang TT   +7 more
core   +1 more source

Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus. [PDF]

open access: yesMicrobiol Spectr, 2023
Negatu DA, Aragaw WW, Dartois V, Dick T.
europepmc   +1 more source

Tuberculosis in the European Region. [PDF]

open access: yesCurr Trop Med Rep, 2023
Mencarini J   +3 more
europepmc   +1 more source

Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections. [PDF]

open access: yesAntimicrob Agents Chemother, 2023
Negatu DA   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy